In 2005, when 70 percent of Americans and a majority in Congress favored loosening restrictions on embryonic stem cell research, state legislators in Indiana passed a bill that prohibited the sale of human ovum, zygote, embryo, or fetus and research on aborted living or nonliving embryos and cloned embryos but allowed fetal stem cell research on placenta, cord blood, amniotic fluid, or fetal tissue with the written consent of the biological parent. With an eye on the potential economic benefits of being a biotechnology-friendly state, the same bill authorized the creation of an adult stem cell center. A feasibility study led by Hal Broxmeyer, director of the Walther Oncology Center and a pioneer in stem cell studies, and Eric Meslin, director of the Indiana University ...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles